143 related articles for article (PubMed ID: 32924602)
21. Tropomyosin 2 Regulates Tumor Cell Proliferation, Immune Suppression, and Activation of the JNK Signaling Pathway in Colitis-Associated Cancer (CAC).
Sun A; Ge J; Ding K; Gao Z; Zhang Y
Discov Med; 2024 Apr; 36(183):778-787. PubMed ID: 38665026
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer.
Pastille E; Faßnacht T; Adamczyk A; Ngo Thi Phuong N; Buer J; Westendorf AM
Front Immunol; 2021; 12():669747. PubMed ID: 34025672
[TBL] [Abstract][Full Text] [Related]
23. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
Xu H; Li J; Chen H; Ghishan FK
Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
[TBL] [Abstract][Full Text] [Related]
24. Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer.
Leon-Cabrera SA; Molina-Guzman E; Delgado-Ramirez YG; Vázquez-Sandoval A; Ledesma-Soto Y; Pérez-Plasencia CG; Chirino YI; Delgado-Buenrostro NL; Rodríguez-Sosa M; Vaca-Paniagua F; Ávila-Moreno F; Gutierrez-Cirlos EB; Arias-Romero LE; Terrazas LI
Cancer Immunol Res; 2017 May; 5(5):385-396. PubMed ID: 28385737
[TBL] [Abstract][Full Text] [Related]
25. Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
Burgueño JF; Fritsch J; González EE; Landau KS; Santander AM; Fernández I; Hazime H; Davies JM; Santaolalla R; Phillips MC; Diaz S; Dheer R; Brito N; Pignac-Kobinger J; Fernández E; Conner GE; Abreu MT
Gastroenterology; 2021 Feb; 160(3):797-808.e6. PubMed ID: 33127391
[TBL] [Abstract][Full Text] [Related]
26. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer.
Bai B; Wu F; Ying K; Xu Y; Shan L; Lv Y; Gao X; Xu D; Lu J; Xie B
Theranostics; 2021; 11(13):6225-6239. PubMed ID: 33995655
[TBL] [Abstract][Full Text] [Related]
28. Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.
Fukata M; Hernandez Y; Conduah D; Cohen J; Chen A; Breglio K; Goo T; Hsu D; Xu R; Abreu MT
Inflamm Bowel Dis; 2009 Jul; 15(7):997-1006. PubMed ID: 19229991
[TBL] [Abstract][Full Text] [Related]
29. AOM/DSS Induced Colitis-Associated Colorectal Cancer in 14-Month-Old Female Balb/C and C57/Bl6 Mice-A Pilot Study.
Schepelmann M; Kupper N; Gushchina V; Mesteri I; Manhardt T; Moritsch S; Müller C; Piatek K; Salzmann M; Vlasaty A; Eferl R; Kallay E
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563665
[TBL] [Abstract][Full Text] [Related]
30. miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition.
Lin L; Wang D; Qu S; Zhao H; Lin Y
Drug Des Devel Ther; 2020; 14():1127-1141. PubMed ID: 32214798
[TBL] [Abstract][Full Text] [Related]
31. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.
Uronis JM; Mühlbauer M; Herfarth HH; Rubinas TC; Jones GS; Jobin C
PLoS One; 2009 Jun; 4(6):e6026. PubMed ID: 19551144
[TBL] [Abstract][Full Text] [Related]
32. Dietary cocoa protects against colitis-associated cancer by activating the Nrf2/Keap1 pathway.
Pandurangan AK; Saadatdoust Z; Esa NM; Hamzah H; Ismail A
Biofactors; 2015; 41(1):1-14. PubMed ID: 25545372
[TBL] [Abstract][Full Text] [Related]
33. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.
Yan S; Chang J; Hao X; Liu J; Tan X; Geng Z; Wang Z
Phytomedicine; 2022 Jul; 102():154217. PubMed ID: 35660350
[TBL] [Abstract][Full Text] [Related]
34. Wumei Pill Ameliorates AOM/DSS-Induced Colitis-Associated Colon Cancer through Inhibition of Inflammation and Oxidative Stress by Regulating S-Adenosylhomocysteine Hydrolase- (AHCY-) Mediated Hedgehog Signaling in Mice.
Wang J; Ding K; Wang Y; Yan T; Xu Y; Deng Z; Lin W; Zhang L; Zhu W; Zhao R; Zhou Y; Liu Z
Oxid Med Cell Longev; 2022; 2022():4061713. PubMed ID: 35927991
[TBL] [Abstract][Full Text] [Related]
35. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice.
Liu M; Xie W; Wan X; Deng T
Int Immunopharmacol; 2020 Nov; 88():106862. PubMed ID: 32771947
[TBL] [Abstract][Full Text] [Related]
36. Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid.
Zheng L; Riehl TE; Stenson WF
Gastroenterology; 2009 Dec; 137(6):2041-51. PubMed ID: 19732774
[TBL] [Abstract][Full Text] [Related]
37. Zerumbone Restores Gut Microbiota Composition in ETBF Colonized AOM/DSS Mice.
Cho HW; Rhee KJ; Eom YB
J Microbiol Biotechnol; 2020 Nov; 30(11):1640-1650. PubMed ID: 32958727
[TBL] [Abstract][Full Text] [Related]
38. T-Cell-Specific CerS4 Depletion Prolonged Inflammation and Enhanced Tumor Burden in the AOM/DSS-Induced CAC Model.
El-Hindi K; Brachtendorf S; Hartel JC; Oertel S; Birod K; Merz N; Trautmann S; Thomas D; Weigert A; Schäufele TJ; Scholich K; Schiffmann S; Ulshöfer T; Utermöhlen O; Grösch S
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163788
[TBL] [Abstract][Full Text] [Related]
39. Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.
Suzuki R; Fukui T; Kishimoto M; Miyamoto S; Takahashi Y; Takeo M; Mitsuyama T; Sakaguchi Y; Uchida K; Nishio A; Okazaki K
J Crohns Colitis; 2015 Jul; 9(7):565-74. PubMed ID: 25908723
[TBL] [Abstract][Full Text] [Related]
40. An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer.
Kuai Y; Liu H; Liu D; Liu Y; Sun Y; Xie J; Sun J; Fang Y; Pan H; Han W
Theranostics; 2020; 10(15):6743-6757. PubMed ID: 32550901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
